Adesola Odunayo

Dr. Adesola Odunayo


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2010 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
AOAdesola Odunayo
Adesola Odunayo
JDJohn R. Dodam
John R. Dodam
MKMarie E. Kerl
Marie E. Kerl
ADAmy E. DeClue
Amy E. DeClue

31 March 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Open access
PDF file
EDElizabeth B. Davidow
Elizabeth B. Davidow
SBShauna L. Blois
Shauna L. Blois
IGIsabelle Goy‐Thollot
Isabelle Goy‐Thollot
LHLauren Harris
Lauren Harris
KHKaren Humm
Karen Humm
KWK. Jane Wardrop
K. Jane Wardrop
Objective: To use a systematic, evidence‐based consensus process to develop definitions for transfusion reactions in dogs and cats.Design: Evidence evaluation of the literature was carried out for identified transfusion reaction types in dogs and cats. Reaction definitions were generated based on synthesis of human and veterinary literature. Consensus on the definitions was achieved through Delphi‐style surveys. Draft recommendations were made available through industry specialty listservs and comments were incorporated.Results: Definitions with imputability criteria were developed for 14 types of transfusion reactions.Conclusions: The evidence review and consensus process resulted in definitions that can be used to facilitate future veterinary transfusion reaction research.

10 March 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Open access
PDF file
EDElizabeth B. Davidow
Elizabeth B. Davidow
SBShauna L. Blois
Shauna L. Blois
IGIsabelle Goy‐Thollot
Isabelle Goy‐Thollot
LHLauren Harris
Lauren Harris
KHKaren Humm
Karen Humm
KWK. Jane Wardrop
K. Jane Wardrop
Objective: To systematically review available evidence to develop guidelines for the prevention of transfusion reactions and monitoring of transfusion administration in dogs and cats.Design: Evidence evaluation of the literature (identified through Medline searches through Pubmed and Google Scholar searches) was carried out for identified transfusion reaction types in dogs and cats. Evidence was evaluated using PICO (Population, Intervention, Comparison, Outcome) questions generated for each reaction type. Evidence was categorized by level of evidence (LOE) and quality (Good, Fair, or Poor). Guidelines for prevention and monitoring were generated based on the synthesis of the evidence. Consensus on the final recommendations and a proposed transfusion administration monitoring form was achieved through Delphi‐style surveys. Draft recommendations and the monitoring form were made available through veterinary specialty listservs and comments were incorporated.Results: Twenty‐nine guidelines and a transfusion administration monitoring form were formulated from the evidence review with a high degree of consensusConclusions: This systematic evidence evaluation process yielded recommended prevention and monitoring guidelines and a proposed transfusion administration form. However, significant knowledge gaps were identified, demonstrating the need for additional research in veterinary transfusion medicine.

24 December 2014 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
SPS. Parkinson
S. Parkinson
KTK. Tolbert
K. Tolbert
KMK. Messenger
K. Messenger
AOAdesola Odunayo
Adesola Odunayo
MBM. Brand
M. Brand
MPMark G. G. Papich
Mark G. G. Papich
Background: Acid suppressant drugs are a mainstay of treatment for cats with gastrointestinal erosion and ulceration. However, clinical studies have not been performed to compare the efficacy of commonly PO administered acid suppressants in cats. Hypothesis/Objectives: To compare the effect of PO administered famotidine, fractionated omeprazole tablet (fOT), and omeprazole reformulated paste (ORP) on intragastric pH in cats. We hypothesized that both omeprazole formulations would be superior to famotidine and placebo. Animals: Six healthy adult DSH colony cats. Methods: Utilizing a randomized, 4-way crossover design, cats received 0.88–1.26 mg/kg PO q12h fOT, ORP, famotidine, and placebo (lactose capsules). Intragastric pH monitoring was used to continuously record intragastric pH for 96 hours beginning on day 4 of treatment. Plasma omeprazole concentrations at steady state (day 7) were determined by high performance liquid chromatography (HPLC) with ultraviolet detection. Mean percentage time that intragastric pH was ≥3 and ≥4 were compared among groups using ANOVA with a posthoc Tukey-Kramer test (α = 0.05). Results: The mean percentage time ± SD that intragastric pH was ≥3 was 68.4 ± 35.0% for fOT, 73.9 ± 23.2% for ORP, 42.8 ± 18.6% for famotidine, and 16.0 ± 14.2% for placebo. Mean ± SD plasma omeprazole concentrations were similar in cats receiving fOT compared to those receiving ORP and in a range associated with acid suppression reported in other studies. Conclusions and Clinical Importance: These results suggest that both omeprazole formulations provide superior acid suppression in cats compared to famotidine or placebo. Fractionated enteric-coated OT is an effective acid suppressant despite disruption of the enteric coating.

10 March 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Open access
PDF file
AOAdesola Odunayo
Adesola Odunayo
KNKatherine J Nash
Katherine J Nash
EDElizabeth B. Davidow
Elizabeth B. Davidow
SBShauna L. Blois
Shauna L. Blois
IGIsabelle Goy‐Thollot
Isabelle Goy‐Thollot
KWK. Jane Wardrop
K. Jane Wardrop
Objective: To systematically review available evidence to develop guidelines for diagnosis and treatment of transfusion‐associated reactions in dogs and cats.Design: Standardized and systemic evaluation of the literature (identified through Medline via PubMed and Google Scholar searches) was carried out for identified transfusion reaction types in dogs and cats. The available evidence was evaluated using PICO (Population, Intervention, Comparison, Outcome) questions generated for each reaction type. The evidence was categorized by level of evidence (LOE) and quality (Good, Fair, or Poor). Guidelines, diagnostic, and treatment algorithms were generated based on the evaluation of the evidence. Consensus on the final guidelines was achieved through Delphi‐style surveys. Draft recommendations were disseminated through veterinary specialty listservs for review and comments, which were evaluated and integrated prior to final publication.Results: Medline via PubMed and Google Scholar databases were searched. There were 14 Population Intervention Comparison Outcome questions identified and corresponding worksheets were developed focusing on the diagnosis and treatment of transfusion‐associated reactions in dogs and cats. Fourteen guidelines and four algorithms were developed with a high degree of consensus.Conclusions: This systematic evidence evaluation process yielded recommended diagnostic and treatment algorithms for use in practice. However, significant knowledge gaps were identified, demonstrating the need for additional research in veterinary transfusion medicine.

1 February 2017 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
AOAdesola Odunayo
Adesola Odunayo
KGKayode Garraway
Kayode Garraway
BRBarton W. Rohrbach
Barton W. Rohrbach
ARAmanda Rainey
Amanda Rainey
JSJennifer Stokes
Jennifer Stokes
OBJECTIVE To determine the incidence of incompatible crossmatch results in dogs without a history of prior RBC transfusion and to evaluate changes in Hct following RBC administration for transfusion-naïve dogs that did and did not have crossmatching performed. DESIGN Retrospective study. ANIMALS 169 client-owned dogs. PROCEDURES Information obtained from the medical records included signalment, pretransfusion Hct or PCV, and crossmatching results where applicable. Dogs that underwent major crossmatching (n = 149) as part of pretransfusion screening were each crossmatched with 3 potential donors. Donor blood was obtained from a commercial source and tested negative for dog erythrocyte antigens (DEAs) 1.1, 1.2, and 7 but positive for DEA 4. Mean change in Hct after transfusion was compared between crossmatch-tested dogs (57/91 that subsequently underwent RBC transfusion) and 20 other dogs that underwent RBC transfusion without prior crossmatching by statistical methods. RESULTS 25 of 149 (17%) dogs evaluated by crossmatching were incompatible with 1 or 2 of the 3 potential donors. All 149 dogs were compatible with ≥ 1 potential donor. Mean ± SD change in Hct after transfusion was significantly higher in dogs that had crossmatching performed (12.5 ± 8.6%) than in dogs that did not undergo crossmatching (9.0 ± 4.3%). CONCLUSIONS AND CLINICAL RELEVANCE Results indicated immunologic incompatibility can exist between first-time transfusion recipients and potential blood donor dogs. The clinical importance of these findings could not be evaluated, but considering the potential for immediate or delayed hemolytic transfusion reactions or shortened RBC life span, the authors suggest veterinarians consider crossmatching all dogs prior to transfusion when possible.